30
Participants
Start Date
April 30, 1999
Primary Completion Date
February 28, 2005
Study Completion Date
May 31, 2008
filgrastim
carmustine
cisplatin
cyclophosphamide
etoposide
thiotepa
adjuvant therapy
autologous bone marrow transplantation
bone marrow ablation with stem cell support
peripheral blood stem cell transplantation
Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, New York
National Cancer Institute (NCI)
NIH
Herbert Irving Comprehensive Cancer Center
OTHER